Challenges for the FDA: the future of drug safety : workshop summary
Gespeichert in:
Körperschaft: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Washington, DC
National Academies Press
c2007
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 Volltext |
Beschreibung: | Includes bibliographical references (p. 78-79) Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future |
Beschreibung: | 1 Online-Ressource (xvii, 109 p.) |
ISBN: | 0309109868 0309109876 1281093556 9780309109864 9780309109871 9781281093554 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043099275 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 151126s2007 |||| o||u| ||||||eng d | ||
020 | |a 0309109868 |9 0-309-10986-8 | ||
020 | |a 0309109876 |c electronic bk. |9 0-309-10987-6 | ||
020 | |a 1281093556 |9 1-281-09355-6 | ||
020 | |a 9780309109864 |9 978-0-309-10986-4 | ||
020 | |a 9780309109871 |c electronic bk. |9 978-0-309-10987-1 | ||
020 | |a 9781281093554 |9 978-1-281-09355-4 | ||
035 | |a (OCoLC)290490622 | ||
035 | |a (DE-599)BVBBV043099275 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 615/.19 |2 22 | |
110 | 2 | |a Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.> |e Verfasser |4 aut | |
245 | 1 | 0 | |a Challenges for the FDA |b the future of drug safety : workshop summary |c Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs |
264 | 1 | |a Washington, DC |b National Academies Press |c c2007 | |
300 | |a 1 Online-Ressource (xvii, 109 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references (p. 78-79) | ||
500 | |a Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future | ||
610 | 1 | 7 | |a United States / Food and Drug Administration |2 fast |
610 | 2 | 4 | |a United States |b Food and Drug Administration |x Rules and practice |
650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
650 | 7 | |a Drugs / Safety measures |2 fast | |
650 | 7 | |a Drugs / Testing |2 fast | |
650 | 4 | |a Drug Approval / Congresses / United States | |
650 | 4 | |a Drug Toxicity / Congresses / United States | |
650 | 4 | |a Product Surveillance, Postmarketing / Congresses / United States | |
650 | 4 | |a Medizin | |
650 | 4 | |a Drugs |z United States |x Testing |v Congresses | |
650 | 4 | |a Drugs |z United States |x Safety measures |v Congresses | |
651 | 4 | |a USA | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
700 | 1 | |a Pray, Leslie A. |e Sonstige |4 oth | |
700 | 1 | |a Robinson, Sally |e Sonstige |4 oth | |
710 | 2 | |a Institute of Medicine (U.S.) |b Forum on Drug Discovery, Development, and Translation |e Sonstige |4 oth | |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897 |x Aggregator |3 Volltext |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-028523466 | ||
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175507567149056 |
---|---|
any_adam_object | |
author_corporate | Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.> |
author_corporate_role | aut |
author_facet | Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.> |
author_sort | Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.> |
building | Verbundindex |
bvnumber | BV043099275 |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)290490622 (DE-599)BVBBV043099275 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03303nmm a2200625zc 4500</leader><controlfield tag="001">BV043099275</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2007 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309109868</subfield><subfield code="9">0-309-10986-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309109876</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-10987-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1281093556</subfield><subfield code="9">1-281-09355-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309109864</subfield><subfield code="9">978-0-309-10986-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309109871</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-10987-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781281093554</subfield><subfield code="9">978-1-281-09355-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)290490622</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043099275</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">22</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Challenges for the FDA</subfield><subfield code="b">the future of drug safety : workshop summary</subfield><subfield code="c">Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xvii, 109 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 78-79)</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future</subfield></datafield><datafield tag="610" ind1="1" ind2="7"><subfield code="a">United States / Food and Drug Administration</subfield><subfield code="2">fast</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States</subfield><subfield code="b">Food and Drug Administration</subfield><subfield code="x">Rules and practice</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Safety measures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Testing</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Toxicity / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Product Surveillance, Postmarketing / Congresses / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">United States</subfield><subfield code="x">Testing</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="z">United States</subfield><subfield code="x">Safety measures</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pray, Leslie A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robinson, Sally</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028523466</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV043099275 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:17:23Z |
institution | BVB |
isbn | 0309109868 0309109876 1281093556 9780309109864 9780309109871 9781281093554 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028523466 |
oclc_num | 290490622 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 Online-Ressource (xvii, 109 p.) |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 2007 |
publishDateSearch | 2007 |
publishDateSort | 2007 |
publisher | National Academies Press |
record_format | marc |
spelling | Symposium on the Future of Drug Safety: Challenges for the FDA <2007, Washington, D.C.> Verfasser aut Challenges for the FDA the future of drug safety : workshop summary Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs Washington, DC National Academies Press c2007 1 Online-Ressource (xvii, 109 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references (p. 78-79) Addressing the FDA's Resource Challenges -- Strengthening the Scientific Base of the Agency -- Integrating Pre- and Postmarket Review -- Enhancing Postmarket Safety Monitoring -- Conducting Confirmatory Drug Safety and Efficacy Studies -- Enhancing the Value of Clinical Trial Registration -- Enhancing Postmarket Regulation and Enforcement -- Looking to the Future United States / Food and Drug Administration fast United States Food and Drug Administration Rules and practice MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drugs / Safety measures fast Drugs / Testing fast Drug Approval / Congresses / United States Drug Toxicity / Congresses / United States Product Surveillance, Postmarketing / Congresses / United States Medizin Drugs United States Testing Congresses Drugs United States Safety measures Congresses USA (DE-588)1071861417 Konferenzschrift gnd-content Pray, Leslie A. Sonstige oth Robinson, Sally Sonstige oth Institute of Medicine (U.S.) Forum on Drug Discovery, Development, and Translation Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897 Aggregator Volltext |
spellingShingle | Challenges for the FDA the future of drug safety : workshop summary United States / Food and Drug Administration fast United States Food and Drug Administration Rules and practice MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drugs / Safety measures fast Drugs / Testing fast Drug Approval / Congresses / United States Drug Toxicity / Congresses / United States Product Surveillance, Postmarketing / Congresses / United States Medizin Drugs United States Testing Congresses Drugs United States Safety measures Congresses |
subject_GND | (DE-588)1071861417 |
title | Challenges for the FDA the future of drug safety : workshop summary |
title_auth | Challenges for the FDA the future of drug safety : workshop summary |
title_exact_search | Challenges for the FDA the future of drug safety : workshop summary |
title_full | Challenges for the FDA the future of drug safety : workshop summary Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs |
title_fullStr | Challenges for the FDA the future of drug safety : workshop summary Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs |
title_full_unstemmed | Challenges for the FDA the future of drug safety : workshop summary Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Leslie Pray and Sally Robinson, rapporteurs |
title_short | Challenges for the FDA |
title_sort | challenges for the fda the future of drug safety workshop summary |
title_sub | the future of drug safety : workshop summary |
topic | United States / Food and Drug Administration fast United States Food and Drug Administration Rules and practice MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drugs / Safety measures fast Drugs / Testing fast Drug Approval / Congresses / United States Drug Toxicity / Congresses / United States Product Surveillance, Postmarketing / Congresses / United States Medizin Drugs United States Testing Congresses Drugs United States Safety measures Congresses |
topic_facet | United States / Food and Drug Administration United States Food and Drug Administration Rules and practice MEDICAL / Drug Guides MEDICAL / Pharmacology MEDICAL / Pharmacy MEDICAL / Nursing / Pharmacology Drugs / Safety measures Drugs / Testing Drug Approval / Congresses / United States Drug Toxicity / Congresses / United States Product Surveillance, Postmarketing / Congresses / United States Medizin Drugs United States Testing Congresses Drugs United States Safety measures Congresses USA Konferenzschrift |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=209897 |
work_keys_str_mv | AT symposiumonthefutureofdrugsafetychallengesforthefda2007washingtondc challengesforthefdathefutureofdrugsafetyworkshopsummary AT praylesliea challengesforthefdathefutureofdrugsafetyworkshopsummary AT robinsonsally challengesforthefdathefutureofdrugsafetyworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation challengesforthefdathefutureofdrugsafetyworkshopsummary |